BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15485312)

  • 1. Experimental approaches for the treatment of malignant gliomas.
    Arko L; Katsyv I; Park GE; Luan WP; Park JK
    Pharmacol Ther; 2010 Oct; 128(1):1-36. PubMed ID: 20546782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.
    Garcia MA; Solomon DA; Haas-Kogan DA
    Future Oncol; 2016 Jun; 12(12):1493-506. PubMed ID: 27072750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine in neuro-oncology.
    Levin VA
    CNS Oncol; 2016; 5(2):55-8. PubMed ID: 26997307
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic treatment of adult gliomas: a narrative review].
    Mangel L
    Magy Onkol; 2024 Mar; 68(1):67-75. PubMed ID: 38484377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the mechanisms of diffuse midline glioma cell migration toward therapeutic targeting.
    Mack SC; Bertrand KC
    Neuro Oncol; 2024 Mar; 26(3):569-570. PubMed ID: 38279953
    [No Abstract]   [Full Text] [Related]  

  • 6. circ_0030018 promotes glioma proliferation and metastasis.
    Shao Y; Yang Z; Miao W; Yu X; Wu Y; Pu Y
    Transl Neurosci; 2021 Jan; 12(1):260-272. PubMed ID: 34150336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells.
    Song K; Yuan Y; Lin Y; Wang YX; Zhou J; Gai QJ; Zhang L; Mao M; Yao XX; Qin Y; Lu HM; Zhang X; Cui YH; Bian XW; Zhang X; Wang Y
    Am J Cancer Res; 2018; 8(5):792-809. PubMed ID: 29888103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.
    Zou S; Zhu Y; Wang B; Qian F; Zhang X; Wang L; Fu C; Bao H; Xie M; Gao S; Yu R; Shi H
    Mol Neurobiol; 2017 Sep; 54(7):5008-5016. PubMed ID: 27534417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme.
    Manaspon C; Nasongkla N; Chaimongkolnukul K; Nittayacharn P; Vejjasilpa K; Kengkoom K; Boongird A; Hongeng S
    Pharm Res; 2016 Dec; 33(12):2891-2903. PubMed ID: 27495180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.
    Khangembam BC; Karunanithi S; Sharma P; Kc SS; Kumar R; Julka PK; Kumar R; Bal C
    Neuroradiology; 2014 Oct; 56(10):893-902. PubMed ID: 24989883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.
    Mimeault M; Batra SK
    Chin Med; 2011 Aug; 6():31. PubMed ID: 21859497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging.
    Xu JL; Li YL; Lian JM; Dou SW; Yan FS; Wu H; Shi DP
    Neuroradiology; 2010 Dec; 52(12):1193-9. PubMed ID: 20571787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor receptors signaling in glioblastoma cells: therapeutic implications.
    Carapancea M; Alexandru O; Fetea AS; Dragutescu L; Castro J; Georgescu A; Popa-Wagner A; Bäcklund ML; Lewensohn R; Dricu A
    J Neurooncol; 2009 Apr; 92(2):137-47. PubMed ID: 19043776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted molecular therapy of malignant gliomas.
    Kesari S; Ramakrishna N; Sauvageot C; Stiles CD; Wen PY
    Curr Oncol Rep; 2006 Jan; 8(1):58-70. PubMed ID: 16464405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Treatment of Malignant Gliomas.
    Gilbert MR; Loghin M
    Curr Treat Options Neurol; 2005 Jul; 7(4):293-303. PubMed ID: 15967092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted molecular therapy of malignant gliomas.
    Kesari S; Ramakrishna N; Sauvageot C; Stiles CD; Wen PY
    Curr Neurol Neurosci Rep; 2005 May; 5(3):186-97. PubMed ID: 15865884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for recurrent malignant glioma in adults.
    Mrugala MM; Kesari S; Ramakrishna N; Wen PY
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):759-82. PubMed ID: 15485312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the response of recurrent malignant gliomas treated with interferon alpha with tumor interferon alpha gene content.
    Olson JJ; James CD; Lawson D; Hunter S; Tang G; Billingsley J
    Int J Oncol; 2004 Aug; 25(2):419-27. PubMed ID: 15254740
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.